DMRA Stock: Price, Earnings History and SEC Filings
Damora Therapeutics, Inc. (DMRA) last traded at $21.49, down 2.36% on the latest session and up 1.0% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.39 against an analyst estimate of $-0.38, a miss of 2.6%.
$21.49 -2.36%
1 month+0.99%
52-week high$38.33
52-week low$4.95
Volume339,518
ExchangeNasdaqCM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
DMRA earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 10, 2026 | $-0.39 | $-0.38 | -2.63% |
| Mar 2026 | May 12, 2026 | $-0.62 | $-0.21 | -195.24% |
DMRA beat the analyst EPS estimate in 0 of its last 2 reported quarters. Source: Nasdaq.
Latest SEC filings for DMRA
SEC filing data is not available right now. You can search for DMRA on SEC EDGAR.
DMRA news
No recent headlines found. The live terminal has the full news feed.
About Damora Therapeutics, Inc.
Damora Therapeutics, Inc. (DMRA) is a US-listed public company on Nasdaq.